Stanford doctor discusses FDA's delayed approval of Alzheimer's drug
CBS News Bay Area anchor Ryan Yamamoto talks with Dr. Michael Greicius, professor of neurology and neurological sciences at Stanford Medicine, about how donanemab is supposed to work, and why the FDA made the decision to pull back on approval for now